{"id":3611,"date":"2020-02-12T16:27:36","date_gmt":"2020-02-12T15:27:36","guid":{"rendered":"https:\/\/idibell.cat\/es\/?page_id=3611"},"modified":"2023-03-01T10:27:12","modified_gmt":"2023-03-01T09:27:12","slug":"terapia-con-celulas-madre-pluripotenciales","status":"publish","type":"page","link":"https:\/\/idibell.cat\/es\/investigacion\/area-medicina-regenerativa-es\/programa-de-medicina-regenerativa\/terapia-con-celulas-madre-pluripotenciales\/","title":{"rendered":"Terapia con c\u00e9lulas madre pluripotenciales"},"content":{"rendered":"\n
Generaci\u00f3n alog\u00e9nica de hiPSC a partir de unidades de sangre de cord\u00f3n umbilical con haplotipos homocig\u00f3ticos HLA frecuentes.<\/p>\n
Terapia celular con epitelio pigmentario retiniano derivado de hiPSC y progenitores fotorreceptores en un modelo porcino de atrofia geogr\u00e1fica.<\/p>\n
Edici\u00f3n del genoma con CRISPR \/ Cas9 en embriones humanos para el estudio del desarrollo embrionario temprano.<\/p>\n\t\t\t\t\tPublicaciones seleccionadas<\/a>\n\t\t\t\t\t\t\t\t\t\t\tExpand<\/i><\/a>\n\t\t\t\t\t \u00c1lvarez Palomo B, Veiga A, Raya A, Codinach M, Torrents S, Ponce Verdugo L, Rodriguez Aierbe C, Cuellar L, Alenda R, Arbona C, Hern\u00e1ndez Maraver D, Fust\u00e9 C, Querol S. Public Cord Blood Banks as a source of starting material for clinical grade HLA-homozygous induced pluripotent stem cells.<\/strong> Stem Cell Res. Ther. 2022;13(1):408-408. doi:10.1186\/s13287-022-02961-6.<\/p>\n Mart\u00ednez Moreno R, Carreras D, Aran B, Kuebler B, Sarquella Brugada G, Brugada R, P\u00e9rez GJ, Scornik FS, Selga E. Generation of four induced pluripotent stem cell lines from a family harboring a single nucleotide variant in SCN5A<\/strong>. Stem Cell Res. 2022;63102847-102847. doi:10.1016\/j.scr.2022.102847.<\/p>\n Mart\u00ednez Moreno R, P\u00e9rez Serra A, Carreras D, Aran B, Kuebler B, Brugada R, Scornik FS, P\u00e9rez GJ, Selga E. Generation of an induced pluripotent stem cell line from a healthy Caucasian male.<\/strong> Stem Cell Res. 2022;60102717-102717. doi:10.1016\/j.scr.2022.102717.<\/p>\n Carrasco B, Pons MC, Parriego M, Boada M, Garc\u00eda S, Polyzos NP, Veiga A. Male and female blastocysts: any difference other than the sex?<\/strong>. Reprod. Biomed. Online. 2022;45(5):851-857. doi:10.1016\/j.rbmo.2022.05.004.<\/p>\n Gianaroli L, Veiga A, Gordts S, Ebner T, Woodward B, Plas C, van Groesen W, Sgargi S, Kovacic B. ESHRE certification of ART centres for good laboratory and clinical practice<\/strong>. Hum. Reprod. Open. 2022;2022(4):doi:10.1093\/hropen\/hoac040.<\/p>\n\t\t\t\t\tProyectos seleccionados<\/a>\n\t\t\t\t\t\t\t\t\t\t\tExpand<\/i><\/a>\n\t\t\t\t\t CEE21042. Haplo-iPS: Generattion of human induced pluripotent stem cells from haplo-selected cord blood simples<\/strong>. COST ACTION. Budget: 125000. 2022-2026. PI: Veiga Lluch, Ana M\u00aa.<\/p>\n 20MEC006. iPS-PANIA: iPSC alog\u00e9nicas a partir de unidades de SCU Homozigotas para haplotipos de elevada prevalencia<\/strong>. Ministerio de Ciencia e Innovaci\u00f3n. Budget: 122060. 2018-2022. PI: Veiga Lluch, Ana M\u00aa.<\/p>\n 21FIS042. Plataforma de BioBancos y Biomodelos: Unidad integrada del Biobanco y del Banco de L\u00edneas Celulares de IDIBELL BioCellBanK PT20\/00171<\/strong>. Instituto de Salud Carlos III (ISCIII). Budget: 167750. 2021-2023. PI: Veiga Lluch, Ana M\u00aa.<\/p>\n 20PSJ008. Puesta a punto de la metodolog\u00eda para la edici\u00f3n gen\u00f3mica CRISPR\/Cas9 en embriones humanos para el estudio del desarrollo embrionario temprano (EMBRYOCRISPR)<\/strong>. Fundaci\u00f3n Merck Salud. Budget: 30000. 2020-2023. PI: Veiga Lluch, Ana M\u00aa.<\/p>\n 20PSJ011. Edici\u00f3n gen\u00f3mica mediante CRISPR\/Cas9 en embriones humanos para el estudio del desarrollo embrionario temprano (EMBRYOCRISPR)<\/strong>. Instituto de Salud Carlos III (ISCIII) y Sociedad Espa\u00f1ola de Fertilidad \/ Instituto Europeo de Fertilidad SLP. Budget: 15000. 2020-2022. PI: Veiga Lluch, Ana M\u00aa.<\/p>\n\t\t\t\t\n Terapia con c\u00e9lulas madre pluripotenciales Resumen El objetivo del grupo es desarrollar y mejorar las metodolog\u00edas para la generaci\u00f3n y diferenciaci\u00f3n de c\u00e9lulas madre pluripotentes (PSC), tanto c\u00e9lulas madre embrionarias humanas (hESC) como c\u00e9lulas madre pluripotentes inducidas por humanos (hiPSC) para su aplicaci\u00f3n cl\u00ednica en terapia celular. El grupo est\u00e1 trabajando en la generaci\u00f3n y […]<\/p>\n","protected":false},"author":6,"featured_media":0,"parent":3588,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"disabled","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"footnotes":""},"publishpress_future_action":{"enabled":false,"date":"2024-05-13 02:10:54","action":"change-status","newStatus":"draft","terms":[],"taxonomy":""},"_links":{"self":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/pages\/3611"}],"collection":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/comments?post=3611"}],"version-history":[{"count":5,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/pages\/3611\/revisions"}],"predecessor-version":[{"id":22159,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/pages\/3611\/revisions\/22159"}],"up":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/pages\/3588"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/media?parent=3611"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}\n\t\tVeiga Lluch, Anna\n\t<\/h4>\n
\n\t\t\n\t\t aveiga@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n
\n\t\tInvestigadores principales\n\t<\/h2>\n\t\t\t\t\n
\n\t\tVeiga Lluch, Anna\n\t<\/h4>\n
\n\t\t\n\t\t aveiga@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n
\n\t\tENLACES RELACIONADOS\n\t<\/h4>\n
\n\t\t\n\t\t@aveiga2\n\t\t<\/a>\n\t<\/h4>\n
\n\t\tEquipo\n\t<\/h2>\n\t\t\t\t\t\t\t\t\t\t\t\tJefes\/as de grupo\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tInvestigadores\/as postdoctorales\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tSoporte cient\u00edfico\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tSoporte administrativo\t\t\t\t<\/a>\n\t\t\t\t\t\tJefes\/as de grupo\n\t\t\t\t\t\t\t\t\t\t\t
\n
\n
\n
\n
\n\t\tNoticias relacionadas\n\t<\/h2>\n\t\t\n\t\t\t\t<\/a>\n\t\t\tInicio de un proyecto para crear una red de colaboraci\u00f3n para la generaci\u00f3n de c\u00e9lulas madre compatibles con un alto porcentaje de la poblaci\u00f3n<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t13\/10\/2022\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tHomenajean con un mural a la Dra. Anna Veiga<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t25\/05\/2022\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tComienza el programa de intercambio entre el IDIBELL y el SZBL<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t06\/05\/2022\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tLa medicina personalizada, uno de los pilares del IDIBELL<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t16\/12\/2021\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tAnna Veiga, nueva Ombudsperson del IDIBELL<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t30\/07\/2020\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tEl P-CMR[C] estrena p\u00e1gina web<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t09\/06\/2020\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tEl proyecto de la Dra. Anna Veiga para poner a punto la edici\u00f3n gen\u00e9tica de embriones humanos recibe la Ayuda Merck para la Investigaci\u00f3n<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t30\/04\/2020\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tEl IDIBELL y Dexeus Mujer estudiar\u00e1n el desarrollo embrionario mediante la edici\u00f3n gen\u00e9tica de embriones humanos<\/a>\n\t\t\tBy Idibell<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t10\/02\/2020\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tResoluci\u00f3n de la convocatoria de expresi\u00f3n de inter\u00e9s (EoI) para proyectos de colaboraci\u00f3n en medicina regenerativa 2019<\/a>\n\t\t\tBy Idibell<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t27\/11\/2019\t\t\t\t\t\t\t\n\t\t\n\n","protected":false},"excerpt":{"rendered":"